Contract 75N95026D00002
Kymanox Corp · Department Of Health And Human Services · June 25, 2026
Kymanox Corp was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on June 25, 2026 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. If all options are exercised, the contract could reach $49.89 million.
Contract details
- PIID
- 75N95026D00002
- Award type
- —
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- First action
- June 25, 2026
Description
"EO 14398"; IDIQ: CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES FOR DEVELOPMENT OF DRUG PRODUCTS (TRND 3)
Modification timeline
-
June 25, 2026Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
| Eminent Services Corp | Department Of Health And Human Services | June 24, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95026D00002?
Contract 75N95026D00002 is a federal contract awarded to Kymanox Corp by Department Of Health And Human Services on June 25, 2026 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N95026D00002?
Kymanox Corp won contract 75N95026D00002 from Department Of Health And Human Services.
How much is contract 75N95026D00002 worth?
Contract 75N95026D00002 has obligated $0 to date but carries a potential ceiling of $49.89 million if fully funded and all options are exercised.